Stockreport

OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency

Opko Health, Inc.  (OPK) 
Last opko health, inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NYSE Investor Relations: investor.opko.com
PDF — Results demonstrated potential to reduce current dosing frequency from once-daily to a single weekly injection — MIAMI and NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE [Read more]